Cancer Immunotherapies May Deploy Nonimmune Cells Engineered to a “T” – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Cancer Immunotherapies May Deploy Nonimmune Cells Engineered to a "T"
Genetic Engineering & Biotechnology News Alternatively, cancer immunotherapies could assemble antitumor units consisting of both engineered immune cells, such as chimeric antigen receptor T (CAR–T) cells, and engineered nonimmune cells, including cells outfitted with “synthetic T-cell … |
